Surgical Innovations Group plc (AIM:SUN)

Paramount Global Income Statement

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	11.95	12.01	11.34	9.13	6.33
Revenue Growth (YoY)	-0.57%	5.94%	24.26%	44.19%	-41.03%
Cost of Revenue	8.51	8.57	7.42	6	5.06
Gross Profit	3.44	3.45	3.92	3.13	1.27
Selling, General & Admin	2.71	2.63	2.42	2.13	2.01
Research & Development	1.15	1.1	1.16	0.97	1.1
Operating Expenses	4.07	4.04	3.85	3.53	4.96
Operating Income	-0.64	-0.59	0.07	-0.4	-3.68
Interest Expense	-0.1	-0.13	-0.1	-0.13	-0.14
Interest & Investment Income	-	-	-	-	0
EBT Excluding Unusual Items	-0.74	-0.72	-0.03	-0.53	-3.82
Asset Writedown	-1.16	-	-	-	-
Other Unusual Items	-0.15	-0.01	-0.03	-0.05	0.51
Pretax Income	-2.05	-0.73	-0.06	-0.59	-3.31
Income Tax Expense	-0.11	-0.22	-0.32	-0.13	-0.03
Net Income	-1.94	-0.51	0.26	-0.46	-3.28
Net Income to Common	-1.94	-0.51	0.26	-0.46	-3.28
Shares Outstanding (Basic)	933	933	933	937	835
Shares Outstanding (Diluted)	933	933	936	939	837
Shares Change (YoY)	-	-0.33%	-0.30%	12.18%	5.95%
EPS (Basic)	-0.00	-0.00	0.00	-0.00	-0.00
EPS (Diluted)	-0.00	-0.00	0.00	-0.00	-0.00
Free Cash Flow	-0.14	0.12	-0.17	-0.65	1
Free Cash Flow Per Share	-	-	-	-0.00	0.00
Gross Margin	28.77%	28.70%	34.59%	34.31%	20.10%
Operating Margin	-5.34%	-4.89%	0.64%	-4.41%	-58.19%
Profit Margin	-16.27%	-4.24%	2.33%	-5.00%	-51.76%
Free Cash Flow Margin	-1.18%	0.97%	-1.53%	-7.07%	15.80%
EBITDA	-0.37	-0.34	0.24	-0.14	-3.17
EBITDA Margin	-3.12%	-2.85%	2.12%	-1.58%	-50.13%
D&A For EBITDA	0.27	0.25	0.17	0.26	0.51
EBIT	-0.64	-0.59	0.07	-0.4	-3.68
EBIT Margin	-5.34%	-4.89%	0.64%	-4.41%	-58.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.